Gyre Therapeutics (GYRE) Reports In-Line Q4 EPS
Get Alerts GYRE Hot Sheet
Join SI Premium – FREE
Gyre Therapeutics (NASDAQ: GYRE) reported Q4 EPS of $0.00. Revenue for the quarter came in at $27.87 million.
For earnings history and earnings-related data on Gyre Therapeutics (GYRE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westport Fuel Systems (WPRT) Misses Q2 EPS by 64c
- Kyverna Therapeutics, Inc. (KYTX) Tops Q2 EPS by 45c
- Owlet (OWLT) Tops Q2 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share